@spvdy2's peptide claims about CJC and ipamorelin, fact-checked

What did @spvdy2 actually say?

The creator described running a stack of CJC-1295 no-DAC, ipamorelin, and IGF-1, then briefly stopping during travel and noticing how quickly hunger spiked when they resumed. They report going from 183 lbs to 205 lbs at 6'2", estimating 15-18% body fat, with arm measurements jumping from "barely 13 inches" to "14.25 inches" without a pump. They're now testing whether dropping IGF-1 causes arm size to shrink, which would indicate the gains were mostly water and glycogen rather than contractile tissue. They're also using a GLP-1 receptor agonist (referred to as "reda" and "semaglutide" context strongly implied) at roughly 3 mg to counter the appetite stimulation from their peptide stack.

Does the science back this up?

The hunger-amplifying effect of GHRH/GHRP combinations is real and documented. The arm-size claim is harder to evaluate without a controlled baseline.

CJC-1295 stimulates growth hormone-releasing hormone (GHRH) receptor activity, and ipamorelin acts as a ghrelin mimetic at the GHS-R1a receptor. Both pathways are known to stimulate ghrelin-adjacent hunger signaling. Sigalos and Pastuszak (2018, Sexual Medicine Reviews) reviewed GH secretagogues and confirmed appetite stimulation as a consistent side effect. Whether this reaches the level the creator describes, needing a GLP-1 agonist to compensate, is plausible but highly individual. On arm size: a 1.25-inch increase in arm circumference over a peptide cycle is aggressive. Most of that change, as the creator themselves admits, is likely intramuscular glycogen storage and water retention from elevated IGF-1 activity, not myofibrillar hypertrophy. That self-awareness is actually commendable.

What did they get wrong (or right)?

They got the mechanism directionally correct but oversimplified. The IGF-1 drop-off test is actually reasonable science thinking.

Where they went sideways: framing this as a clean muscle-building outcome. IGF-1 drives glucose uptake and glycogen synthesis in muscle cells via PI3K/Akt signaling (Clemmons, 2009, Nature Reviews Drug Discovery), so fuller-looking muscles after IGF-1 use is largely a nutrient partitioning and glycogen story, not new fiber growth in a matter of weeks. The creator seems to understand this at the end, which is worth crediting. Where they got it right: the self-experiment logic of removing IGF-1 to isolate its effect is actually a reasonable n=1 washout approach. And the acknowledgment that eating 5-6 meals a day "just fine" once back on peptides is a textbook description of ghrelin-pathway activation. The semaglutide counter-measure is a real clinical tool, though using 3 mg to offset peptide-induced hunger is not a standard protocol and carries its own risk profile.

What should you actually know?

These peptides are not FDA-approved for performance use, and the stack described carries real physiological and regulatory risks that the video glosses over entirely.

CJC-1295 and ipamorelin are research compounds. They are not approved by the FDA for bodybuilding, fat loss, or general "optimization." Compounded versions vary in purity and potency. The combination with an injectable GLP-1 agonist at the doses implied here adds cardiovascular and gastrointestinal risks that a 5.8K-view TikTok doesn't have the space to address. Elevated IGF-1 over time is also not consequence-free. Renehan et al. (2004, The Lancet) found associations between circulating IGF-1 levels and cancer risk in observational data, a finding that hasn't gone away in 20 years of follow-up literature. None of this means these compounds have zero legitimate clinical use. But self-dosing a multi-peptide stack plus a GLP-1 agent based on scale weight and a tape measure is not the same as supervised therapy.

The bottom line

The creator is doing something more thoughtful than most peptide content: they're actively testing their own claims. But the video still normalizes a complex, unmonitored hormonal intervention.

The hunger amplification claim is scientifically plausible. The arm size gains are almost certainly mostly glycogen and water, which the creator half-admits. The broader framing of this stack as a reliable body recomposition tool skips over the regulatory status of these compounds, the purity and dosing variability in unregulated supply chains, and the longer-term hormonal risks of sustained GH axis stimulation. If you're considering peptide therapy, that conversation starts with a licensed provider who can actually run bloodwork, not a TikTok update at 205 lbs.